Navigation Links
Multiple Presentations Featuring QNEXA® Data to be Presented at the European Congress on Obesity
Date:5/20/2011

MOUNTAIN VIEW, Calif., May 20, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that multiple abstracts will be presented at the upcoming European Congress on Obesity meeting to be held May 25 to May 28, 2011, at the ICEC Lutfi Kirdar Convention & Exhibition Center in Istanbul, Turkey.  The details of the presentations are as follows:Oral presentation:Friday, May 27 – Novel Drugs Session, Presentation time 17:15-17:30 (local time)Authors:  

Stephan Rossner, MD, PhD; Craig A. Peterson, MS; Barbara Troupin, MD, MBATitle:  

CARDIOMETABOLIC RISK REDUCTION IS DIRECTLY RELATED TO MAGNITUDE OF WEIGHT LOSS WITH LOW DOSE, CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE (PHEN/TPM CR) [T5:RS4.4]Poster presentations:Thursday, May 26– Hot Topic Poster Session, Presentation time 13:00-15:00 (local time)Authors:  

George A. Bray, MD; Louis J. Aronne, MD; Alok K. Gupta, MD; Wesley W. Day, PhD; Barbara Troupin, MD, MBATitle:  

EFFICACY AND TOLERABILITY OF TOPIRAMATE ALONE AND IN COMBINATION WITH PHENTERMINE [HTP.025]Friday, May 27– Poster Session, Presentation time 13:00-15:00 (local time)Authors:  

W. Timothy Garvey, MD; Craig A. Peterson, MS; Barbara Troupin, MD, MBATitle:  

WEIGHT LOSS WITH LOW-DOSE, CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE THERAPY IMPROVES GLYCAEMIC STATUS AND PREVENTS PROGRESSION TO TYPE 2 DIABETES MELLITUS [T5:P.102]Authors:  

W. Timothy Garvey, MD; Wesley W. Day, PhD, Charles H. Bowden, MDTitle:  

LONG-TERM TREATMENT WITH CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE DEMONSTRATES SUSTAINED WEIGHT LOSS OVER 108 WEEKS [T5:P.103]All posters will be displayed in the Exhibition Hall from the afternoon of May 25th until the morning of May 28th.

About QNEXA Controlled Release CapsulesQNEXA [kyoo-nek-suh] is an investigational drug c
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Mass. , Dec. 18, 2014  Decision Resources ... the United States will increase to ... will be primarily driven by expansion in the large ... energy devices will be increasingly adopted due to the ... Other key findings from Decision Resources Group,s ...
(Date:12/19/2014)... 18, 2014   Aratana Therapeutics, Inc . ... focused on the licensing, development and commercialization of ... results from its pivotal field study of AT-001 ... in dogs with osteoarthritis.  In the study, dogs ... that were statistically significant compared to placebo (p<0.05) ...
(Date:12/17/2014)... Revenue and earnings above the previous ... development In the past 2013/14 fiscal year (ended ... to EUR 4.287 billion (last year: EUR 4.190 billion) despite ... EUR 360 million. "Overall, 2013/14 was a successful fiscal year ... President and CEO of Carl Zeiss AG. "Thanks to our ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS Asserts its Position in Difficult Environment 2
... 18 Epiphany Biosciences announced results from its Phase ... shingles (herpes zoster) infection. The study,s primary endpoint ... in terms of time to complete crusting of the ... randomized into 3 arms: 1 gram of once-daily ...
... Nov. 18 Covance Inc. (NYSE: CVD ), ... it entered into a biomarker alliance and services agreement with ... biomarker testing to the pharmaceutical industry. , Subject to the ... exclusive third-party provider of multiplexed protein biomarker testing services, and ...
Cached Medicine Technology:Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles. 2Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles. 3Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. 2Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. 3Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. 4
(Date:12/17/2014)... Nwe is the co-author of a new weight loss book ... the Ace Medical Weight Loss Center in Rock Hill, SC. ... the industry of weight loss, and how several fad diets ... television shows, however, she says the topic of obesity is ... basic laughs, which she believes impacts whether Americans view it ...
(Date:12/17/2014)... RI (PRWEB) December 17, 2014 ... recognize private practices that have made outstanding and ... in support and progression of private practice physical ... American Physical Therapy Association. , On behalf of ... OCS, owner and CEO of Performance accepted the ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 A group of ... for Longevity, today, in reaction to a recent statement by ... of brain training and derogated the efficacy of all brain ... agreed with the parts of the center’s statement critical of ... the center had also overstated its case, in a document ...
(Date:12/17/2014)... No matter how far modern medicine advances, ... head louse parasite—a common childhood malady and a source ... six and twelve million individuals will suffer an infestation. ... company comes to the rescue, providing an all-natural treatment ... track record of customer service, and effectiveness in getting ...
(Date:12/17/2014)... 2014 Project Veritas is releasing a ... of MIT economist and Obamacare architect Jonathan Gruber to ... conducted the interview, which is being distributed on YouTube. ... intentional mislabeling in the Affordable Care Act in order ... two-hundred-and-fifty billion dollar per year tax grab. , “President ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2
... Attacks New York Department of ,Hype, with New York Times Ad ... (CCF) is running a full-page ad in the New York Times ... Department of Health,s hyperbolic "Don,t drink yourself fat" PSA campaign. The Center ... News and New York Post that ask New Yorkers, ...
... economic times, many business owners cut back and take a ... area cosmetic surgeon, has watched other cosmetic practices lock their ... conclusion that his medical spa and surgery center simply will ... to open another location in the ,Uptown, Dallas area. "I ...
... Oct. 1 Today, MSN released ... that helps people manage their health information on the Web. ... a variety of tools and widgets to upload, organize and ... The new service allows people to research medical concerns, read ...
... ... in stock, but supplies are expected to sell out quickly. Businesses and schools ... Purell on hand before the demand peaks as a result of the H1N1 ... company has 4.25 oz bottles, 12 oz pump bottles, 8 oz pump bottles ...
... ... the eleventh edition of the Biotech Beach™ Hotbed Campaign this morning. , ... Englewood, CO (Vocus) October 1, ... unveiled the eleventh edition of the Biotech Beach™ Hotbed Campaign this morning. , , ...
... ... TCSterps On-Demand, a comprehensive Video Relay Interpreting (VRI) service providing Sign Language Interpreting ... ... -- TCS Associates , ( http://www.TCSassociates.com ) a total solutions provider for ...
Cached Medicine News:Health News:Consumer Group Continues Million Dollar Campaign Responding to NYC Health Officials' Hyperbolic PSA Campaign 2Health News:Beauty and the Economy: Unusual Timing for Dallas Uptown Medi-Spa Launch 2Health News:Beauty and the Economy: Unusual Timing for Dallas Uptown Medi-Spa Launch 3Health News:MSN Introduces Online Tools to Help People Make Smarter Health and Lifestyle Decisions 2Health News:MSN Introduces Online Tools to Help People Make Smarter Health and Lifestyle Decisions 3Health News:Swine Flu Expected to Hit Hard - Purell Hand Sanitizer in Stock at CleanItSupply.com 2Health News:Swine Flu Expected to Hit Hard - Purell Hand Sanitizer in Stock at CleanItSupply.com 3Health News:BioSpace Launches the 2010 Biotech Beach Hotbed Campaign 2Health News:TCS Associates: A Sign Language Interpreting Agency Launches New Video Remote Interpreting (VRI) Service called TCSterps On-Demand 2Health News:TCS Associates: A Sign Language Interpreting Agency Launches New Video Remote Interpreting (VRI) Service called TCSterps On-Demand 3
... tonometer is an easy-to-use, hand-held instrument ... strongly with Goldmann tonometry. TONO-PEN AVIA ... advanced electronic measurement technology that enables ... IOP measurements with minimal training. TONO-PEN ...
... The six models of Thermo Scientific ... mL to 60 mL with very high ... careful design of all components. The Finnpipette ... the extensive Thermo Scientific Finnpipette manual liquid ...
... Digital Flexible Ureteroscope (DUR-D) incorporates many ... proven durable, market leading DUR® series ... first device utilizing Gyrus ACMIs proprietary, ... Metal Oxide Semi-Conductor (CMOS) distal sensor ...
... Sunglasses collection benefits from innovative research in ... sectors such as the aerospace and automotive ... field and the footwear and textile industry. ... reinvented in the Carrera sunglasses collection to ...
Medicine Products: